期刊文献+

胰岛素强化治疗对不同病程的2型糖尿病胰岛功能的影响 被引量:2

原文传递
导出
摘要 目的观察不同病程的2型糖尿病患者胰岛素强化治疗2周后胰岛功能的变化。方法将74例确诊的2型糖尿病患者按病程分成三组:A组25例,病程〈5年;B组25例,病程5.10年;C组24例,病程〉10年。对三组患者均采用胰岛素泵连续皮下输注,对比治疗前后血糖、C肽水平。结果治疗后三组患者血糖均显著下降(P〈0.01),胰岛功能变化不一:A组治疗前空腹c肽(2.30±1.08)ug/L、餐后2hC肽(9.09±5.41)ug/L,治疗后分别为(2.76±0.83)、(10.95±4.80)ug/L,空腹C肽、餐后2hC肽均有明显改善(P〈0.01);B组治疗前空腹C肽(2.26±0.96)ug/L、餐后2hC肽(8.31±4.25)ug/L,治疗后分别为(2.46±0.93)、(8.55±3.49)ug/L,空腹C肽有明显改善(P〈0.01),餐后2hC肽无明显改善(P〉0.05);C组治疗前空腹c肽(2.18±0.78)ug/L、餐后2hc肽(8.16±2.69)ug/L,治疗后分别为(2.29±0.71)、(8.20±2.47)ug/L,空腹c肽、餐后2hC肽均无明显改善(P〉0.05)。结论不论病程长短,2型糖尿病患者经胰岛素泵强化治疗均可明显降低血糖;病程≤10年的患者胰岛功能可不同程度地得到改善,其中病程〈5年的患者收益最多,病程越长,收益越少;病程〉10年的患者胰岛功能没有得到改善,已发生不可逆的衰退。
出处 《中国医师进修杂志》 2011年第25期39-40,共2页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献6

  • 1Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care, 2004,27 ( 11 ) : 2597-2602.
  • 2Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a muhicentre randomised parallel-group trial. Lancet,2008,371(9626): 1753-1760.
  • 3Rolla A. The pathophysiological basis for intensive insulin replacement. Int J Obes Relat Metab Disord,2004,28 Suppl 2:S3-7.
  • 4Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes,2004,53 Suppl 3: S16- 21.
  • 5冯尤健,陈祥彪,刘桑燕,巫晓强,刘碧玲.新诊断2型糖尿病患者两种短期胰岛素强化治疗的疗效比较[J].中国糖尿病杂志,2008,16(1):40-41. 被引量:35
  • 6Pankowska E, Blazik M, Dziechciarz P, et al. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes,2009,10 ( 1 ) : 52- 58.

二级参考文献5

共引文献34

同被引文献25

  • 1李霞,周智广,亓海英,陈小燕,黄干.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能[J].中南大学学报(医学版),2004,29(4):419-423. 被引量:211
  • 2李玲,李素玮,厉平,张毅,尚晓静,刘聪,王艳军,岳桂英.空腹C肽质量浓度与胰岛素抵抗相关性研究[J].中国实用内科杂志:临床前沿版,2006,26(5):767-768. 被引量:9
  • 3李延兵,朱大龙,田浩明,时立新,罗佐杰,严励,曾龙驿,周智广,杨立勇,刘娟,李明,翁建平.新诊断2型糖尿病患者β细胞功能分析[J].中华医学杂志,2006,86(36):2537-2541. 被引量:28
  • 4Sivitz WI. Lipotoxicity and glucotoxicity in type 2 diabetes Efects on development and progression. Postgrad Med,2001,109 ( 1 ) : 55.
  • 5Dailey GE. Early insuli:an important therapeutic strategy. Diabe- tes Care ,2005,28( 1 ) :220-221.
  • 6American Diabetes Association. Report-of the expert committee on the diagnosis snd dassiiieation of diabetes mellltus. Dibetes care, 1997,20 : 1183-1197.
  • 7IDF Clinical Guidelines Task Force, Global Guidelines for Type 2 Diabetes: recommendations for standard, comprehensive, and min- imal car. Diabet Med,2006,23(6) :579-593.
  • 8Li YB, XuW, Liao ZH, et al. Inducton of longterm glyeemic con- tr01. in newly diagnosed type 2 diabetic patients is associated with improvement of IB-cellfunction. Diabetes Care, 2004,27 ( 11 ) : 2597-2602.
  • 9Gerich JE. Is reduced first-phase insulin release the earliest de- tectable abnormality in individuals destined to develop type 2 dia- betes. Diabetes,2002,51 ( Suppl 1 ) : 117-121.
  • 10Kahn SE ,Montgomery B ,Howell W,et aL Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab, 2001,86 (12) : 5824-5829.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部